HOME >> BIOLOGY >> NEWS
Jefferson researchers uncover new way nature turns genes on and off

(PHILADELPHIA) Peering deep within the cells of fruit flies, developmental biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia may have discovered a new way that genes are turned on and off during development. If they're right, and the same processes are at work in higher organisms, including mammals, the findings could eventually have implications for improving the understanding of a range of diseases, including childhood cancer.

Reporting in the journal Cell, Alexander Mazo, Ph.D., professor of biochemistry and molecular biology at Jefferson Medical College, Svetlana Petruk, Ph.D., and their co-authors focused on pieces of genetic material called non-coding (nc)RNAs. About two-thirds of the human genome is converted into such RNAs (the better known messenger RNAs are translated into proteins), though the function of the majority is unknown. The researchers detailed a possible mechanism by which ncRNAs briefly control the functioning of homeotic, or HOX, genes, which guide the master developmental plan of the organism.

"We think that this new mechanism operates early in embryogenesis," says Dr. Mazo.

According to Dr. Mazo, the researchers found that one of the likely mechanisms behind ncRNAs' ability to regulate essential coding genes is through a "transcription interference" mechanism. "Such mechanisms are known in bacteria and yeast, but not much is known in higher organisms," he explains.

In the fruit fly, HOX gene activity is maintained by genes and proteins in the Trithorax group (TrxG). These proteins are thought to act through so-called maintenance elements, one of which, in a nearby region, bxd, is located between two HOX genes, Ubx and abd-A. Dr. Mazo explains that several "long" ncRNAs are transcribed through bxd maintenance elements. They were thought to be expressed in the same cells as Ubx, and to regulate HOX gene coding sequence expression. But the researchers found something
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
27-Dec-2006


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Tiny genes may increase cancer susceptibility, Jefferson scientists find
4. Jefferson scientists use gene therapy to reverse heart failure in animals
5. Jefferson researchers discovery may change thinking on how viruses invade the brain
6. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
7. Jefferson scientists find rabies-based vaccine could be effective against HIV
8. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
9. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
10. Jefferson scientists find guardian genes choices crucial to stopping cancer process
11. Jefferson researchers develop combined procedure for uterine preservation in treating fibroids

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... uBiome, the leader in microbial ... uses artificial intelligence (AI) and a data-centric approach to decentralize medicine using blockchain ... , People will Crohn’s or other chronic medical conditions join a relevant study ...
(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
(Date:1/10/2019)... , ... January 10, 2019 , ... ... the translational gap between inexpensive in vitro studies and significantly more expensive in ... in vivo efficacy and toxicity. To address this need, researchers have begun to ...
Breaking Biology News(10 mins):
(Date:2/12/2019)... SAN FRANCISCO (PRWEB) , ... February 12, 2019 ... ... (CRO) specializing in dermatology, has finalized a deal to extend their use of ... diagnostics clinical trials, through 2023. The CRO has been a regular Medrio customer ...
(Date:2/2/2019)... ... February 01, 2019 , ... Biomatlante, a ... of its new CEO, Julien Dert, being effective on February 1st, 2019. , ... finance and management, in which more than 12 years in the Medical Device ...
(Date:1/30/2019)... ... January 29, 2019 , ... K&R Negotiations announced today that Mladen ... special online event titled: Six Ways to Shorten the Sales Cycle : Reduce ... 2019 on the BrightTALK network. , Negotiation expert Kresic will discuss the realities ...
(Date:1/28/2019)... ... January 28, 2019 , ... ... low molecular weight compounds. In this early stage, false positives can be problematic ... time, it is vital that screening techniques are highly sensitive to detect weak ...
Breaking Biology Technology:
Cached News: